EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

Translational Lung Cancer Research ◽

10.21037/tlcr.2020.03.02 ◽

2020 ◽

Vol 9 (2) ◽

pp. 239-245 ◽

Author(s):

Anna Buder ◽

Maximilian J. Hochmair ◽

Ulrike Setinek ◽

Robert Pirker ◽

Martin Filipits

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Faculty Opinions recommendation of Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725853745.793510697 ◽

2015 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Consolidation Therapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

P3.13-16 Concomitant EML4-ALK Rearrangement and EGFR Mutation in Non-Small Cell Lung Cancer Patients: Data from Eastern Indian Hospital.

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1856 ◽

2018 ◽

Vol 13 (10) ◽

pp. S982

Author(s):

P. Mohapatra ◽

S. Bhuniya ◽

M. Panigrahi ◽

S. Patra ◽

P. Mishra ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Alk Rearrangement ◽

Lung Cancer Patients

Download Full-text

Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.01.011 ◽

2020 ◽

Vol 21 (3) ◽

pp. 273-280.e4 ◽

Author(s):

Ichidai Tanaka ◽

Masahiro Morise ◽

Ayako Miyazawa ◽

Yuta Kodama ◽

Yutaro Tamiya ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Platinum Based Chemotherapy ◽

Potential Benefits

Download Full-text

P2.01-90 PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients with or without EGFR Mutation

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1144 ◽

2018 ◽

Vol 13 (10) ◽

pp. S699-S700

Author(s):

T. Siripoon ◽

P. Incharoen ◽

N. Trachu ◽

D. Munthum ◽

K. Kamprerasart ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Predictive Biomarker ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Abstract 1674: Prediction of survival based on tumor size dynamics and new lesions in EGFR mutation-positive non-small cell lung cancer patients treated with gefitinib or carboplatin and paclitaxel

10.1158/1538-7445.am2019-1674 ◽

2019 ◽

Author(s):

James Dunyak ◽

Jacqueline Buros-Novik ◽

Eric Novik ◽

Hong Yan ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Prediction Of Survival

Download Full-text

Abstract 1674: Prediction of survival based on tumor size dynamics and new lesions in EGFR mutation-positive non-small cell lung cancer patients treated with gefitinib or carboplatin and paclitaxel

10.1158/1538-7445.sabcs18-1674 ◽

2019 ◽

Author(s):

James Dunyak ◽

Jacqueline Buros-Novik ◽

Eric Novik ◽

Hong Yan ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Prediction Of Survival

Download Full-text

Utility of T790M plasma and tissue biopsy testing in EGFR mutated non-small-cell lung cancer patients

Lung Cancer ◽

10.1016/s0169-5002(20)30167-7 ◽

2020 ◽

Vol 139 ◽

pp. S61-S62

Author(s):

E. Preda ◽

J. Shamash ◽

K. Tarver ◽

S. Ball

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Tissue Biopsy ◽

Download Full-text

Plasmatic Tumor Dna Assessments Predict Clinical Outcome in Egfr-Mutated Non-Small Cell Lung Cancer Patients Treated By Egfr Inhibitors

Annals of Oncology ◽

10.1093/annonc/mdu349.59 ◽

2014 ◽

Vol 25 ◽

pp. iv450

Author(s):

N. Pecuchet ◽

A. Didelot ◽

E. Zonta ◽

C. Lours ◽

L. Gibault ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Outcome ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Download Full-text

Retrospective Efficacy and Safety Analysis of Erlotinib (E), Pemetrexed (P) and Docetaxel (D) in Previously Treated Non-Small-Cell Lung Cancer Patients (NSCLC) without EGFR Mutation

Annals of Oncology ◽

10.1016/s0923-7534(20)33800-x ◽

2012 ◽

Vol 23 ◽

pp. ix437 ◽

Author(s):

J. Takeshita ◽

N. Katakami ◽

A. Nishiyama ◽

H. Yoshioka ◽

M. Iwasaku ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Previously Treated

Download Full-text

P2.03-035 Osimertinib in Relapsed EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases: Results from the TREM-Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1286 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2140-S2141

Author(s):

I.J. Eide ◽

Å. Helland ◽

S. Borrisova ◽

S. Ekman ◽

S. Cicenas ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text